Market Insights Health Medical Technology Medical Devices

Diagnostic Imaging Devices - Romania

Romania

In Romania, the Diagnostic Imaging Devices market market is anticipated to witness a substantial growth in revenue, reaching a projected value of US$243.50m in the year 2024.
This growth is expected to continue with an annual growth rate (CAGR 2024-2029) of 5.34%, ultimately resulting in a market volume of US$315.80m by the year 2029.
It is worth noting that when compared globally, the United States is projected to generate the highest revenue in this market, amounting to US$11,930.00m in the year 2024.
Romania is experiencing a growing demand for advanced diagnostic imaging devices, driven by the expansion of healthcare infrastructure and increasing focus on early disease detection.

Key regions: Germany, Japan, Netherlands, Spain, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Diagnostic Imaging Devices market in Romania is experiencing steady growth due to several factors such as increasing customer preferences for advanced imaging technologies, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Diagnostic Imaging Devices market in Romania are shifting towards more advanced and innovative technologies. Customers are increasingly demanding high-quality images with faster processing times and lower radiation exposure. This has led to the adoption of advanced imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. Customers also prefer devices that are easy to use, portable, and cost-effective. These preferences are driving the demand for innovative diagnostic imaging devices in Romania. Trends in the market include the increasing use of artificial intelligence (AI) and machine learning algorithms in diagnostic imaging devices. These technologies enable faster and more accurate diagnosis, improving patient outcomes. Additionally, there is a growing trend towards the integration of diagnostic imaging devices with electronic health record systems, allowing for seamless data sharing and analysis. Furthermore, the market is witnessing the development of compact and portable imaging devices, which are particularly beneficial in rural areas with limited access to healthcare facilities. Local special circumstances in Romania contribute to the growth of the Diagnostic Imaging Devices market. The country has a large population with a high burden of chronic diseases, such as cardiovascular diseases and cancer. This drives the demand for diagnostic imaging devices for early detection and monitoring of these conditions. Additionally, Romania has a growing elderly population, which increases the need for imaging devices for age-related conditions. Furthermore, the government has been investing in healthcare infrastructure and technology to improve access to quality healthcare services, including diagnostic imaging. Underlying macroeconomic factors also play a role in the development of the Diagnostic Imaging Devices market in Romania. The country has been experiencing economic growth, which has increased disposable income and healthcare spending. This allows individuals and healthcare facilities to invest in advanced diagnostic imaging devices. Additionally, the government has implemented healthcare reforms to improve the efficiency and quality of healthcare services, including the use of diagnostic imaging. These factors contribute to the growth and development of the market in Romania. In conclusion, the Diagnostic Imaging Devices market in Romania is growing steadily due to increasing customer preferences for advanced imaging technologies, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The adoption of innovative technologies, such as AI and machine learning, and the integration of imaging devices with electronic health record systems are driving the market forward. The high burden of chronic diseases, growing elderly population, and government investments in healthcare infrastructure also contribute to the market's growth.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.